Poster Session D

Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)

Format: Virtual Only

(1856–1887) Muscle Biology, Myositis and Myopathies Poster II

Monday, November 14, 2022

1:00 PM – 3:00 PM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

1:00 PM – 3:00 PM Eastern Time

Subclinical Coronary Artery Disease in Patients with Idiopathic Inflammatory Myopathies: A Cross-Sectional Study Evaluation by Computer Tomography Coronary Angiogram
Abstract Poster Presenter: Tsz Ho Luk, MBBS – Kwong Wah Hospital
1:00 PM – 3:00 PM Eastern Time

Increasing Proportion of MDA-5 Associated Conditions in a Tertiary Myositis Centre Following Onset of the Covid-19 Pandemic
Abstract Poster Presenter: Jennifer Hannah, MBBS, MSc, MRCP, MA – Kings College London
1:00 PM – 3:00 PM Eastern Time

A Multi-center Clinical Cohort Study of Chinese Anti-synthetase Syndrome Patients
Abstract Poster Presenter: 明炜唐, MD – Peking Union Medical College
1:00 PM – 3:00 PM Eastern Time

Urinary Beta-2 Microglobulin Is a Sensitive Prognostic Marker in Dermatomyositis Patients with Interstitial Lung Disease Positive for Anti-MDA-5 Antibody
Abstract Poster Presenter: Jun Nakamura, MD, PhD – Jichi Medical University
1:00 PM – 3:00 PM Eastern Time

Lenabasum, a Cannabinoid Type 2 Receptor Agonist, Activates Diverse Cell-specific Pathways in Whole Blood Leukocytes in Dermatomyositis
Abstract Poster Presenter: Nilesh Kodali, BS – New Jersey Medical School
1:00 PM – 3:00 PM Eastern Time

Racial Disparities in Diagnosis and Treatment of Patients with Dermatomyositis of Different Skin Tones
Abstract Poster Presenter: Hillary Weisleder, MD – Montefiore Einstein
1:00 PM – 3:00 PM Eastern Time

Lenabasum Reduces IFNγ and pIRF3 in Dermatomyositis Skin: Biomarker Results from a Double-Blind Phase 3 International Randomized Controlled Trial
Abstract Poster Presenter: Thomas Vazquez, MD – University of Pennsylvania
1:00 PM – 3:00 PM Eastern Time

Aromatase Inhibitor Induced Musculoskeletal Inflammation Is Observed Independent of Oophorectomy in a Novel Mouse Model
Abstract Poster Presenter: Nicholas Young, PhD – The Ohio State University Wexner Medical Center
1:00 PM – 3:00 PM Eastern Time

Hepatitis B Exposure and Infection in Idiopathic Inflammatory Myopathies: Prevalence, Presentation, and Treatment Response
Abstract Poster Presenter: Ana Valle, MD, MHS – Montefiore Medical Center
1:00 PM – 3:00 PM Eastern Time

Internet-based Enrollment for Myositis Studies Utilizing Patient Self-reported Diagnostic Criteria
Abstract Poster Presenter: Raisa Lomanto Silva, MD – University of Pittsburgh Medical Center
1:00 PM – 3:00 PM Eastern Time

Polymyositis/Dermatomyositis Readmissions: Analysis of the Nationwide Readmission Database
Abstract Poster Presenter: Amy Trang, MD – Rush University Medical Center
1:00 PM – 3:00 PM Eastern Time

YKL-40-mediated Inflammatory Pathogenesis Common to Polymyositis / Dermatomyositis
Abstract Poster Presenter: Kazuteru Noguchi, MD – Hyogo Medical University
1:00 PM – 3:00 PM Eastern Time

B Cell Count in Juvenile Dermatomyositis: A Biomarker of Disease
Abstract Poster Presenter: Christopher Costin, MD – Ann & Robert H. Lurie Children's Hospital of Chicago
1:00 PM – 3:00 PM Eastern Time

Looking for BlyS(BAFF) in Juvenile Dermatomyositis: A New Biomarker of Disease Activity
Abstract Poster Presenter: Christopher Costin, MD – Ann & Robert H. Lurie Children's Hospital of Chicago
1:00 PM – 3:00 PM Eastern Time

Clinical Outcomes Following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Vaccination in Patients with Anti-Melanoma Differentiation Associated Gene 5 (MDA5) Antibody Positive Dermatomyositis
Abstract Poster Presenter: Richard Seto, MD – Sutter Health
1:00 PM – 3:00 PM Eastern Time

Hospitalization Outcomes for Acute Myocardial Infraction and Acute Heart Failure in Patients with Idiopathic Inflammatory Myopathies (IIM) from 2016-2019 National Inpatient Sample (NIS)
Abstract Poster Presenter: Zi Ying Li, MD, MPH – Roger Williams Medical Center
1:00 PM – 3:00 PM Eastern Time

Outcome of Idiopathic Inflammatory Myositis Patients Who Received Rituximab: A Single Centre Retrospective Study
Abstract Poster Presenter: Fahidah Alenzi, MD – Princess Nourah bint Abdulrahman University
1:00 PM – 3:00 PM Eastern Time

Relationship Between Baseline Characteristics of Rheumatoid Arthritis and Types of Mortality: Study of Cohort Followed Prospectively
Abstract Poster Presenter: Cristina Corrales, MD – HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA
1:00 PM – 3:00 PM Eastern Time

Autoantibodies Are Common in Patients with Idiopathic Interstitial Lung Disease Suggesting a High Prevalence of Undiagnosed Autoimmune Connective Tissue Disease
Abstract Poster Presenter: Sarah Tansley, PhD, BSc, MBChB – University of Bath
1:00 PM – 3:00 PM Eastern Time

Assessment of Antibody Levels to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) in Patients with Idiopathic Inflammatory Myopathies Receiving Treatment with Intravenous Immunoglobulin
Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

Nailfold Videocapillaroscopic Abnormalities Correlate with Disease Activity Measures and Cutaneous Damage in Patients with Idiopathic Inflammatory Myopathies
Abstract Poster Presenter: Diane Zisa, MD – Columbia University Irving Medical Center
1:00 PM – 3:00 PM Eastern Time

Identification of Serum Biomarkers Associated with Muscle Inflammation Detected on MRI in Polymyositis/dermatomyositis
Abstract Poster Presenter: Haruna Matsuo, MD – Nagasaki University
1:00 PM – 3:00 PM Eastern Time

Analysis of the Association Between the Atrophic Factors Tripartite Motif Containing (TRIM) 63 and Atrogin-1 and the Clinical and Inflammatory Features of Patients with Idiopathic Inflammatory Myopathies
Abstract Poster Presenter: Jiram Torres Ruiz, PhD – INCMNSZ
1:00 PM – 3:00 PM Eastern Time

Vaccine Hesitancy Among Patients with Idiopathic Inflammatory Myopathies and Rheumatic Diseases in 2021-2022: A Comparative Analysis of COVID-19 Vaccination in Autoimmune Diseases Surveys
Abstract Poster Presenter: Naveen R, DM – Sanjay Gandhi Post graduate institute of medical sciences
1:00 PM – 3:00 PM Eastern Time

Association Study Between anti-TIF1γ Antibody and Development of Neoplasia in Three Tertiary Hospitals
Abstract Poster Presenter: Marina Pavia Pascual, MD – Hospital Universitario Puerta de Hierro Majadahonda28020
1:00 PM – 3:00 PM Eastern Time

Efficacy of Immune-apheresis in Patients with Inflammatory Myopathies: A Case Series
Abstract Poster Presenter: Kastriot Kastrati, MD – Division of Rheumatology
1:00 PM – 3:00 PM Eastern Time

Auto-antibodies Targeting Membrane Repair Proteins Enhances Myositis Phenotype
Abstract Poster Presenter: Shane Bruckner, PhD – OSU
1:00 PM – 3:00 PM Eastern Time

Idiopathic Inflammatory Myopathies in Alaska Native/American Indian People in Alaska
Abstract Poster Presenter: Vivek Mehta, MBBS – Alaska Native Tribal Health Consortium
1:00 PM – 3:00 PM Eastern Time

Histopathological Patterns of Muscle Involvement and Clinical Correlations in a Retrospective Cohort of Scleroderma Patients
Abstract Poster Presenter: Noemie Le Gouellec, MD – CH Valenciennes
1:00 PM – 3:00 PM Eastern Time

Statin-induced Immune-mediated Miopathy: Treatment with Glucocorticoid-free Protocols and Role of Muscle Biopsy in the Follow-up
Abstract Poster Presenter: David Martinez-Lopez, MD – Hospital Universitario Marques de Valdecilla
1:00 PM – 3:00 PM Eastern Time

Determining the Long-term Safety and Efficacy of JAK Inhibitors in the Treatment of Dermatomyositis: A Retrospective Cohort Study
Abstract Poster Presenter: Shivani Rangaswamy, BS – Johns Hopkins School of Medicine